A Study to Investigate the Safety and Tolerability of a New Inhaled Formulation of RV568 in Healthy Volunteers

Clinical trial NCT01661244 · COMPLETED

Trial details

NCT number: NCT01661244
Sponsor: Respivert Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

COPD Healthy Volunteers

Start date: 2012-09-01
Primary completion: 2013-02-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.